| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 10/03/2006 | US7115720 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 10/03/2006 | US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 10/03/2006 | US7115662 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 10/03/2006 | US7115637 Inhibitors of p38 |
| 10/03/2006 | US7115635 Benzylpiperidine compound |
| 10/03/2006 | US7115634 4-aminopiperidine and their use as a medicine |
| 10/03/2006 | US7115633 Benzosuberonylpiperdine compounds as analgesics |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115621 Chemical compounds |
| 10/03/2006 | US7115616 Pyrimidinone compounds |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115594 Administering to a patient with metabolic bone disease an effective amount of 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 compound to treat osteoporosis |
| 10/03/2006 | US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines |
| 10/03/2006 | US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| 10/03/2006 | US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
| 09/28/2006 | WO2006102117A1 Nanoparticulate biphosphonate compositions |
| 09/28/2006 | WO2006101187A1 Peptides that increase collagen or hyaluronic acid production |
| 09/28/2006 | WO2006101163A1 Medicinal composition for treating/preventing motor organ disease |
| 09/28/2006 | WO2006101104A1 Agent for treatment of arthritis |
| 09/28/2006 | WO2006100527A1 Effervescent tablet containing sodium alendronate and related use and process |
| 09/28/2006 | WO2006100213A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 09/28/2006 | WO2006099735A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
| 09/28/2006 | WO2006051314A8 Guanidine derivatives as inhibitors of ddah |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217424 Compounds for the inhibition of nitric oxide synthase |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217353 24-sulfoximine vitamin D3 compounds |
| 09/28/2006 | US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 09/28/2006 | US20060217348 Pyrazolo[1,5-a] pyridines and medicines containing the same |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060217313 5-CNAC as oral delivery agent for parathyroid hormone fragments |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216358 Such as strontium ranelate; once daily oral administration; various bone and glandular disorders |
| 09/28/2006 | US20060216325 Composition and device for in vivo cartilagerepair |
| 09/28/2006 | US20060216249 Use of a cosmetic of pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 09/28/2006 | DE102005014080A1 Additionssalze des Tolperison, Verfahren zu deren Herstellung und Verwendung derselben Addition salts of tolperisone, processes for their preparation and use thereof |
| 09/28/2006 | CA2814267A1 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/28/2006 | CA2602479A1 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 09/28/2006 | CA2602374A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 09/28/2006 | CA2601363A1 Nanoparticulate biphosphonate compositions |
| 09/28/2006 | CA2600531A1 Pyrimidine compounds and methods of use |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
| 09/27/2006 | EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/27/2006 | EP1704866A2 TGFbeta superfamily proteins for biological anchoring of connective tissue to bone |
| 09/27/2006 | EP1704862A1 2,5-bis(tetrahydroxybutyl)pyrazines for the treatment of osteoarthritis and rheumatoid arthritis |
| 09/27/2006 | EP1703917A2 Heh4 molecules and uses thereof |
| 09/27/2006 | EP1703906A1 Immuno inhibitory pyrazolone compounds |
| 09/27/2006 | EP1624878B1 Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1511496B1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 09/27/2006 | EP1335906B1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 09/27/2006 | EP1196433B1 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 09/27/2006 | CN1839114A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 09/27/2006 | CN1838952A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 09/27/2006 | CN1837205A Process for the preparation of pyrazolopyridine tartrates |
| 09/27/2006 | CN1836730A Intensified additive for chondroitin sulfate capsule formulation and tablet and its preparation method |
| 09/27/2006 | CN1836725A Traditional Chinese medicine composition for treating arthritis and preparing method thereof |
| 09/27/2006 | CN1836723A Traditional Chinese medicine for treating femoral head necrosis |
| 09/27/2006 | CN1836720A Chinese medicine composition for treating arthritis or gout and preparing method thereof |
| 09/27/2006 | CN1836711A Chinese traditional medicine for treating rheumatism involving the bone |
| 09/27/2006 | CN1836700A Medicine composition for treating cervical vertebra, lumbar vertebrae diseases and preparation method thereof |
| 09/27/2006 | CN1836699A Multifunctional health liquid |
| 09/27/2006 | CN1836693A Chinese medicine composition for treating arthritis and preparing method thereof |
| 09/27/2006 | CN1836685A Use of catechu in preparing drug for treating hyperuricemia |
| 09/27/2006 | CN1836534A Geranium tea and preparation method thereof |
| 09/27/2006 | CN1276925C Antipyretic analgesic medicine |
| 09/27/2006 | CN1276772C Externally-applied medicine for treating hyperosteogeny and its preparation process |
| 09/27/2006 | CN1276768C Chinese traditional medicinal composition for treating hyperosteogeny |
| 09/27/2006 | CN1276763C Chinese traditional medicine composition for treating bedsore and acute soft tissue injury |
| 09/27/2006 | CN1276761C Compound traditional Chinese and western medicine for treating rheumatism and osteoarthritis and productive method thereof |
| 09/27/2006 | CN1276760C Chinese medicine composition and its preparing method |
| 09/27/2006 | CN1276756C Medicine composition for treating osteoporosis and its preparation |
| 09/27/2006 | CN1276749C Medicine for treating scald |
| 09/26/2006 | US7112675 Pyrrolotriazine inhibitors of kinases |
| 09/26/2006 | US7112611 Antitumor, anticancer agents; respiratory system disorders; brain disorders |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112598 κ opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 09/26/2006 | US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 09/26/2006 | US7112584 Antiinflammatory agents; antiarthritic agents; antiallergens; antiinflammatory agents |
| 09/26/2006 | US7112579 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
| 09/26/2006 | US7112577 Pharmaceutically acceptable alendronate salts in amorphous form |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | CA2278694C Sulfamide-metalloprotease inhibitors |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006098519A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097625A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |